Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
PLoS One. 2010 Dec 17;5(12):e14361. doi: 10.1371/journal.pone.0014361.
Burkholderia pseudomallei is the etiological agent of melioidosis, a disease endemic in parts of Southeast Asia and Northern Australia. Currently there is no licensed vaccine against infection with this biological threat agent. In this study, we employed an immunoproteomic approach and identified bacterial Elongation factor-Tu (EF-Tu) as a potential vaccine antigen. EF-Tu is membrane-associated, secreted in outer membrane vesicles (OMVs), and immunogenic during Burkholderia infection in the murine model of melioidosis. Active immunization with EF-Tu induced antigen-specific antibody and cell-mediated immune responses in mice. Mucosal immunization with EF-Tu also reduced lung bacterial loads in mice challenged with aerosolized B. thailandensis. Our data support the utility of EF-Tu as a novel vaccine immunogen against bacterial infection.
类鼻疽伯克霍尔德菌是类鼻疽病的病原体,该病在东南亚部分地区和澳大利亚北部流行。目前,尚无针对这种生物威胁因子感染的许可疫苗。在这项研究中,我们采用免疫蛋白质组学方法,鉴定出细菌延伸因子-Tu(EF-Tu)作为一种潜在的疫苗抗原。EF-Tu 是膜相关的,在外膜囊泡(OMVs)中分泌,并且在类鼻疽病的小鼠模型中,在伯克霍尔德菌感染期间具有免疫原性。用 EF-Tu 进行主动免疫可诱导小鼠产生抗原特异性抗体和细胞介导的免疫反应。用 EF-Tu 进行黏膜免疫也可减少用气溶胶化 B. thailandensis 攻击的小鼠肺部的细菌负荷。我们的数据支持 EF-Tu 作为一种新型疫苗免疫原用于细菌感染的效用。